mifepristone has been researched along with fluticasone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daly, M; Farrow, S; Ray, KP; Searle, N; Talabot, F | 1 |
| Fernandes, D; Guida, E; Harris, T; Koutsoubos, V; Stewart, AG; Vadiveloo, P; Wilson, JW | 1 |
| Kankaanranta, H; Moilanen, E; Zhang, X | 2 |
| Kearns, GL; Leeder, JS; Pearce, RE | 1 |
| Amrani, Y; Brightling, C; Chachi, L; Gavrila, A; Tliba, O | 1 |
6 other study(ies) available for mifepristone and fluticasone
| Article | Year |
|---|---|
Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids.
Topics: Androstadienes; Beclomethasone; Dexamethasone; Dose-Response Relationship, Drug; E-Selectin; Endothelium, Vascular; Fluticasone; Gene Expression Regulation; Genes, Reporter; Glucocorticoids; Humans; Interleukin-1; Mifepristone; NF-kappa B; Promoter Regions, Genetic; Protein Binding; Receptors, Glucocorticoid; Transcriptional Activation; Tumor Necrosis Factor-alpha | 1997 |
Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle.
Topics: Androstadienes; Bronchi; Calcium-Calmodulin-Dependent Protein Kinases; Cell Cycle; Cell Division; Cells, Cultured; Cyclin D1; Dexamethasone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Fluticasone; Glucocorticoids; Humans; Inhibitory Concentration 50; MAP Kinase Kinase 1; Mifepristone; Mitogen-Activated Protein Kinase Kinases; Muscle, Smooth; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Retinoblastoma Protein; Thrombin | 1999 |
Enhancement of human eosinophil apoptosis by fluticasone propionate, budesonide, and beclomethasone.
Topics: Androstadienes; Anti-Asthmatic Agents; Apoptosis; Beclomethasone; Budesonide; Dose-Response Relationship, Drug; Eosinophils; Fluticasone; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-5; Mifepristone; Tumor Necrosis Factor-alpha | 2000 |
Beclomethasone, budesonide and fluticasone propionate inhibit human neutrophil apoptosis.
Topics: Androstadienes; Anti-Inflammatory Agents; Apoptosis; Beclomethasone; Budesonide; Cells, Cultured; Down-Regulation; Fluticasone; Glucocorticoids; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Mifepristone; Neutrophils; Receptors, Glucocorticoid | 2001 |
Biotransformation of fluticasone: in vitro characterization.
Topics: Androstadienes; Anti-Inflammatory Agents; Biotransformation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluticasone; Humans; In Vitro Techniques; Ketoconazole; Kinetics; Lung; Microsomes, Liver; Mifepristone; Recombinant Proteins | 2006 |
Effect of the plant derivative Compound A on the production of corticosteroid-resistant chemokines in airway smooth muscle cells.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Case-Control Studies; Chemokine CCL5; Chemokine CX3CL1; Chemokine CXCL10; Drug Resistance; Dual Specificity Phosphatase 1; Epithelial Cells; Female; Fluticasone; Gene Expression; Humans; Interferon Regulatory Factor-1; Interferon-gamma; Male; Middle Aged; Mifepristone; Primary Cell Culture; Receptors, Glucocorticoid; Respiratory Mucosa; RNA, Small Interfering; Tumor Necrosis Factor-alpha; Tyramine | 2015 |